BHC
NYSE · Pharmaceuticals
Bausch Health Cos Inc
$6.25
+0.34 (+5.75%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.52%
1Y
+8.70%
YTD
-13.31%
Open$5.91
Previous Close$5.91
Day High$6.27
Day Low$5.89
52W High$11.97
52W Low$6.10
Volume—
Avg Volume1.07M
Market Cap3.10B
P/E Ratio—
EPS$-3.24
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$6.64
Below
SMA 200
$6.36
Below
RSI (14)
60
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
8 analysts
Price Target
+1,560.5% upside
Current
$6.25
$6.25
Target
$103.78
$103.78
$65.08
$103.78 avg
$115.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.56B | 12.55B | 415.01M |
| Net Income | 207.45M | 172.70M | 120.28M |
| Profit Margin | 1.5% | 1.5% | 29.0% |
| EBITDA | 3.93B | 3.46B | 156.90M |
| Free Cash Flow | — | — | 115.51M |
| Rev Growth | +8.1% | +8.1% | +10.0% |
| Debt/Equity | 44.72 | 44.72 | 0.48 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |